Keni Ni

Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice

Yasuyuki Mitani, Junko Yarimizu, Kyoko Saita et al. · Journal of Neuroscience · 2012 · 196 citations · Full text

Life Sciences, Neuroscience, Pharmacology +12

Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model

Michihiro Toritsuka, Sohei Kimoto, Kazue Muraki et al. · Proceedings of the National Academy of Sciences · 2013 · 80 citations · Full text

Life Sciences, Genetics, Neuroscience +17

A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease

Katsuya Harada, Kazuhiro Nakato, Junko Yarimizu et al. · European Journal of Pharmacology · 2012 · 61 citations

Medicine, Neuroscience, Pharmacology +12

ASP5736, a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia

Mayako Yamazaki, Katsuya Harada, Noriyuki Yamamoto et al. · European Neuropsychopharmacology · 2014 · 37 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: Validation with olanzapine and ziprasidone

Miwako Shobo, Hiroshi Yamada, Takuma Mihara et al. · Behavioural Brain Research · 2010 · 34 citations

Medicine, Pharmacology, Pharmacotherapy +15